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        Introduction 
  Endothelial cells (ECs) of brain capillaries form an active perme-
ability barrier and transport system known as the blood  –  brain bar-
rier (BBB), which is instrumental in the control of the brain fl  uid 
milieu ( Engelhardt, 2003 ). Complex tight junctions (TJs) between 
brain ECs constituted by proteins of the claudin (Cldn) family and 
occludin (Ocln) seal off the paracellular pathway (  Furuse and 
Tsukita, 2006  ). Whereas Cldn5 is also found in nonbarrier endo-
thelium, Cldn3 is predominantly present in brain ECs, where it 
plays a specifi  c role in the establishment and maintenance of BBB 
TJ morphology (  Wolburg et al., 2003  ;   Nitta et al., 2003  ). 
  BBB ECs also express specifi  c transporters for glucose, 
amino acids, and, to prevent damage to the brain, members of 
the multidrug resistance transporter family (also known as ABC 
transporters;   Engelhardt, 2003  ). ECs rapidly lose their barrier 
and selective transport properties under pathological conditions 
in vivo (ischemia and tumor) and upon cultivation in vitro  ,   indi-
cating that the healthy brain provides inductive and maintenance 
signals for the BBB. Our limited knowledge of the nature of 
these signals and of the molecular regulation of the BBB ham-
pers the development of BBB model systems and patient ther-
apy (  Liebner et al., 2000b  ;   Engelhardt, 2006  ). 
  A major pathway regulating brain development is the 
canonical Wnt/wingless pathway acting via    -catenin  (  -cat) 
stabilization. This favors translocation of     -cat to the nucleus, 
where it binds to transcription factors of the lymphoid enhancer 
factor (Lef)/T cell factor (TCF) family, and thus modulates gene 
T
he blood  –  brain barrier (BBB) is conﬁ  ned to the en-
dothelium of brain capillaries and is indispensable 
for ﬂ  uid homeostasis and neuronal function. In this 
study, we show that endothelial Wnt/    -catenin (    -cat) 
signaling regulates induction and maintenance of BBB 
characteristics during embryonic and postnatal develop-
ment. Endothelial speciﬁ  c stabilization of     -cat in vivo en-
hances barrier maturation, whereas inactivation of     -cat 
causes signiﬁ  cant down-regulation of claudin3 (Cldn3), 
up-regulation of plamalemma vesicle-associated protein, 
and BBB breakdown. Stabilization of     -cat in primary 
brain endothelial cells (ECs) in vitro by N-terminal trunca-
tion or Wnt3a treatment increases Cldn3 expression, BBB-
type tight junction formation, and a BBB characteristic 
gene signature. Loss of     -cat or inhibition of its signaling 
abrogates this effect. Furthermore, stabilization of     -cat 
also increased Cldn3 and barrier properties in nonbrain-
derived ECs. These ﬁ  ndings may open new therapeutic 
avenues to modulate endothelial barrier function and to 
limit the devastating effects of BBB breakdown.
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transcription (  Moon, 2005  ). In this study, we report that Wnt/
    -cat signaling in brain ECs in vitro and in vivo during brain 
angiogenesis and postnatal vascular maturation is necessary to 
induce barrier properties in brain ECs. 
  Results and discussion 
  Active endothelial     -cat signaling correlates 
with central nervous system 
vascularization, BBB development, 
and maturation 
 In     -cat  –  activated transgene driving expression of nuclear 
    -galactosidase reporter (BAT-Gal) mice for Wnt/   -cat  signal-
ing, we observed strong LacZ-reporter activity in ECs starting 
at embryonic day (E) 9.5 when the perineural vascular plexus is 
fully developed (  Fig. 1 A  , a and b). Throughout brain angiogen-
esis up to E15.5, numerous ECs in the immature network were 
LacZ positive (  Fig. 1 B  , a and b). From E15.5 to 17.5, the num-
ber of LacZ-positive nuclei decreased signifi  cantly (  Fig. 1, B   
[c and d] and   C  ) to a level that was maintained during early 
postnatal stages in vessels of the cortex (  Fig. 1, B   [e  –  h] and   C  ). 
Adult brain vessels rarely displayed LacZ-positive nuclei, suggest-
ing that Wnt signaling activity is required for BBB maturation but 
is low when the BBB is fully mature (  Fig. 1 C   and not depicted). 
  Conditional activation or inactivation of 
endothelial     -cat in vivo modulates Cldn3 
and plamalemma vesicle-associated protein 
(Plvap) expression and BBB permeability 
  To understand the role of     -cat in BBB maturation and mainte-
nance, we selectively deleted     -cat in ECs (loss of function 
[LOF]) at postnatal day (P) 4, P7, and P14, corresponding to stages 
of progressive BBB maturation (  Kniesel et al., 1996  ). For this 
purpose, we crossed    cat 
lox/lox   mice with tamoxifen-inducible 
Pdgfb-iCreERT2 mice ( Brault et al., 2001 ;  Claxton et al., 2008 ). 
Cre expression was monitored by EGFP expression (the Pdgfb-
i  CreERT2 allele includes an internal ribosome entry-EGFP se-
quence), and recombination was tracked by crossbreeding with 
ROSA26R::YFP Cre reporter mice (  Srinivas et al., 2001  ; un-
published data). After induction of Cre-mediated recombination 
by 4-hydroxy-tamoxifen (4OHT) in    cat 
lox/lox /Pdgfb-iCreERT2 
mice, immunolabeling for     -cat demonstrated complete absence 
of the protein in nearly all brain vessels at P4 (Fig. S1, available 
at http://www.jcb.org/cgi/content/full/jcb.200806024/DC1) and 
P7 and in     50% at P14 (not depicted). In Cre 
      brains, Cldn3 was 
expressed at low levels in brain vessels at P4 and P7 (Fig. S1) 
and was consistently expressed in all vessels at P14 (  Fig. 2 A  , a  ) . 
In Cre 
+   littermates, Cldn3 was strongly reduced in most brain 
  Figure 1.       Canonical Wnt signaling is active in ECs during brain angiogen-
esis and becomes progressively down-regulated during vessel maturation.   
(A) LacZ whole-mount stained (blue) E9.5 BAT-Gal embryos sectioned and 
counterstained for isolectin B4 (IB4; red). Panel b is a higher magniﬁ  cation 
of the boxed area in panel a. Arrows point to nuclear LacZ reporter gene 
staining. (B, a  –  d) Whole-mount hindbrain staining for LacZ (reﬂ  ection; red) 
and IB4 (green) of BAT-Gal embryos (E13.5 and 17.5) analyzed by confo-
cal microscopy. Arrowheads indicate LacZ-positive nuclei. (B, e  –  h) Staining 
of brain cryosections from postnatal BAT-Gal pups (P1 and P5) for LacZ 
(immunoﬂ  uorescence [IF], red) and IB4 (green). Arrowheads indicate LacZ-
positive nuclei. Positive nuclei outside the vascular system indicate active 
Wnt signaling in the brain parenchyma. (C) Quantiﬁ  cation of LacZ-positive 
nuclei per 100-  μ  m vessel length shows a signiﬁ  cant decrease from E15.5 
to 17.5 (ﬁ  ve ﬁ  elds per hindbrain; three brains; **, P = 0.0003). Error bars 
represent SEM.     
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(  Fig. 2 C  ). To functionally test barrier properties, we injected 
Evans blue i.p. 18 h before tissue harvesting. At P14, extravasated 
Evans blue was apparent around many vessels after endothelial 
    -cat inactivation but not in controls (  Fig. 2 B  ). This effect was 
even more pronounced at earlier (P4 and P7) postnatal stages 
(Fig. S1). Cldn5 was consistently expressed in Cre 
      but was 
vessels at P4 and P7 (Fig. S1) and in approximately half of 
the vessels at P14 (  Fig. 2 A  , d). Conversely, Pvlap was poorly 
expressed in brain vessels of control animals (  Fig. 2 A  , g; and 
Fig. S1) but was strongly up-regulated when     -cat was inacti-
vated (  Fig. 2 A  , j; and Fig. S1). Quantitative RT-PCR analysis of 
total brain RNA confi  rmed strong up-regulation of Plvap mRNA 
  Figure 2.       Conditional     -cat GOF or LOF in ECs in vivo modulates Cldn3 and Plvap expression and permeability in brain capillaries.   P14 brain sections of 
4OHT-treated LOF mice stained for Cldn3 or Plvap together with IB4. (A, a and g) Cre 
      control mice. Arrowheads point to Cldn3-positive and Plvap-negative 
vessels, respectively. (d and j) Cre 
+   LOF resulted in Cldn3 down- and Plvap up-regulation in     50% of brain capillaries. Arrowheads point to Cldn3-
negative and Plvap-positive vessels, respectively.     -Cat GOF in ECs in vivo by 4OHT treatment. E18.5 and P4 brain sections analyzed for Cldn3 or Plvap 
(green) together with IB4 (red). (b, c, h, and i) Cre 
      control mice. Arrowheads point to weak Cldn3-positive vessels at E18.5 and a slightly higher level at 
P4 or strong Plvap at E18.5 and a slightly weaker level at P4. (e, f, k, and l) Cldn3 increase in Cre 
+   mice at E18.5 and P4. Plvap was down-regulated. Left 
panels show merge of IB4 and Cldn3 or Plvap; right panels show Cldn3 or Plvap alone in black and white. Insets show higher magniﬁ  cations. (B) Evans 
blue injection i.p. 18 h before tissue harvesting in LOF mice. Arrowheads point to extravasated Evans blue in Cre 
+   mice at P14. (C) Quantitative RT-PCR 
for Plvap at P7 in LOF (  n   = 3; **, P = 0.0001) and GOF (  n   = 3; *, P = 0.0382). Cldn3 was statistically NS. Control is set to 100% (dashed line). Error 
bars represent SEM.     JCB • VOLUME 183 • NUMBER 3 • 2008  412
zonula occludens 1 (ZO-1) were unchanged and localized to all 
interendothelial junctions (not depicted), whereas plakoglobin 
(Plako) was slightly increased at adherens junctions of Cre 
+  
samples, confi  rming previous data showing that Plako can 
markedly reduced or absent from most Cre 
+   vessels at P4 and 
P7 and strongly reduced in   50% of the vessels at P14, suggesting 
that loss of endothelial     -cat affected the molecular composi-
tion of TJs (Fig. S1). Vascular endothelial cadherin (VE-cad) and 
  Figure 3.       Wnt3aCM but not Wnt5aCM induced TJs and barrier properties in MBEs.   Wild-type MBEs treated with controlCM, Wnt3aCM, or Wnt5aCM in 
vitro. (A, a, e, and i) IHC staining for Cldn3. (b, f, and j) IHC staining for Cldn5. Panels are the same magniﬁ  cation as indicated in panel k. (c, g, and k) 
IHC staining for active     -cat (clone 8E7). Arrowheads point to positive nuclei. (d, h, and l) Freeze-fracture EM. Arrowheads point to P-face  –  associated 
TJ ridges. (B) mRNA levels for Cldn1, Cldn3, Cldn5, Cldn12, Ocln, Plvap, and Axin2 measured by quantitative RT-PCR. Cldn3 (  n   = 3; *, P = 0.0319), 
Plvap (  n   = 3; *, P = 0.0098), and Axin2 (  n   = 3; **, P = 0.005); other tested genes were not signiﬁ  cantly altered. Control is set to 100% (dashed line). 
(C) Western blotting for Cldn3 and Cldn5.     -Tubulin/tubulin     1A served as a loading control. Western blotting for 8E7 and total     -cat. No band could 
be detected in Wnt5aCM-treated cells. See graphs for densiomeric quantiﬁ  cation of bands. Error bars represent SEM. Data are representative of at least 
three independent experiments.     413 WNT/    -CATENIN SIGNALING IN BBB ENDOTHELIA   • Liebner et al. 
[c, g, and k],   B, and C  ) were strongest in Wnt3aCM-treated 
cells,  confi  rming     -cat stabilization by Wnt3aCM. None of 
these parameters were induced by Wnt5aCM. Other junctional 
proteins, including Cldn5, VE-cad,     -cat, Plako, ZO-1, Ocln, 
Cldn1, and Cldn12 were not modifi  ed in distribution and ex-
pression (  Fig. 3   and not depicted). 
  To directly validate the role of     -cat in Cldn expression, 
we genetically deleted or stabilized     -cat in ECs in vitro by 
harvesting brain ECs from   -cat 
lox/lox  and   -cat 
lox(ex3)/lox(ex3)  mice, 
respectively (  Harada et al., 1999  ;   Brault et al., 2001  ). Cells were 
treated with cell-permeable transactivating regulatory protein 
(TAT)  –  Cre to achieve loxP site  –  mediated recombination, thus 
generating     -cat LOF and GOF in vitro (  Wadia et al., 2004  ). 
   -cat 
lox/lox   cells grew and behaved as wild-type cells, showing 
Cldn3 up-regulation upon Wnt3aCM treatment ( Fig. 4, A  [a and b], 
  B, and C  ), an effect abrogated by the loss of    -cat  ( Fig.  4,  A  
[c and h] and   C  ). 
  In contrast,     -cat stabilization led to an increase in 
Cldn3 junctional staining, mRNA, and protein level ( Fig. 4, A  
[d, e, i, and j],   B, and C  ). A double band for     -cat in the Cre 
+ /  -
cat 
lox(ex3)/lox(ex3)   cell extract demonstrates the effective, although 
not complete, recombination of exon3 by the Cre recombinase. 
Thus, the effects of   -cat stabilization are comparable with those 
of stimulating the cells with Wnt3aCM. When we infected a 
nonbrain-derived endothelioma cell line (  Lampugnani et al., 2002  ) 
exhibiting low barrier properties with N-terminal truncated 
    -cat, we observed a signifi  cant increase in Cldn3 and barrier 
properties (freeze-fracture analysis and decrease in Pvlap), sug-
gesting that elevated     -cat transcriptional activity may induce 
BBB properties also in nonbrain-derived ECs (Fig. S3, available 
at http://www.jcb.org/cgi/content/full/jcb.200806024/DC1). 
  Cldn3 up-regulation requires 
transcriptionally active rather than 
junctional localized     -cat in MBEs in vitro 
  To better discriminate the effects of junctional versus transcrip-
tional active     -cat on Cldn3 regulation, we infected MBEs with 
an adenoviral vector containing dominant-negative TCF4 
(dnTCF4;   Quasnichka et al., 2006  ), which inhibits signaling but 
does not affect the junctional pool of   -cat. Alternatively, MBEs 
were infected with a lentiviral vector containing Lef  Δ  N-   CTA, 
which dominantly induces     -cat signaling without binding to 
VE-cad (  Vleminckx et al., 1999  ). Adenoviral infection with 
dnTCF4 completely abrogated the Wnt3aCM-mediated up-
regulation of Cldn3 and Axin2 in primary MBEs, whereas Plvap 
was signifi  cantly up-regulated (  Fig. 5, A   [a  –  c] and   B   [a]). 
  Lentiviral infection of the dominant-active Lef  Δ  N-   CTA 
construct had principally the same, but a notably stronger, effect 
than Wnt3aCM, namely Cldn3 up-regulation and Plvap down-
regulation (  Fig. 5, A   [d] and   B   [b]). Together, these results show 
that the transcriptional activity of     -cat is necessary and suffi  -
cient to up-regulate Cldn3 and down-regulate Plvap, leading to 
increased barrier properties of brain ECs. 
  Cldn3 is an important downstream effector of    -cat  sig-
naling, whereas Cldn5, although affected in vivo by the loss of 
    -cat, appears to be ubiquitous and more stably expressed. 
Although newborn Cldn5-null mice die immediately after birth 
substitute for the loss of     -cat at adherens junctions in ECs 
(Fig. S1;   Cattelino et al., 2003  ). 
  To selectively activate     -cat transcriptional activity in ECs 
(gain of function [GOF]), we crossed    -cat 
lox(ex3)/wt   mice with 
Pdgfb-iCreERT2 mice (  Harada et al., 1999  ;   Claxton et al., 2008 ). 
At E18.5 and P4, Cre 
      mice showed only faint Cldn3 staining 
in brain vessels, whereas Plvap was strongly expressed, con-
fi  rming the immaturity of the BBB at late embryonic and early 
postnatal stages (  Fig. 2 A  , b, c, h, and i). Cre-mediated    -cat 
  activation increased Cldn3 junctional staining at E18.5 and P4 
(  Fig. 2 A  , e and f) and decreased Plvap (  Fig. 2 A  , k and l). Quan-
titative RT-PCR confi  rmed signifi  cant down-regulation of Plvap 
mRNA in Cre 
+   samples (  Fig. 2 C  ). The Cldn3 mRNA level ap-
peared to be increased, although statistical analysis failed to 
show signifi  cant regulation. The low abundance of this gene in 
total brain RNA samples is a likely cause for the observed vari-
ability and isolation of ECs before RNA extraction may be 
required to achieve adequate sensitivity in vivo. Nevertheless, 
even at earlier stages (E13.5), activation of    -cat  transcription 
resulted in detectably stronger junctional Cldn3 staining and re-
duction of Plvap in brain vessels (Fig. S2, available at http://
www.jcb.org/cgi/content/full/jcb.200806024/DC1). Cldn5 expres-
sion and localization was not changed between Cre 
+   and  con-
trol vessels (Fig. S2). Together, these results illustrate that 
endothelial     -cat is required for BBB maturation and func-
tion in vivo and that transcriptional activation of    -cat  acceler-
ates BBB maturation. 
  Activation of endothelial     -cat signaling 
induces barrier characteristics in vitro 
  We next asked whether activation of Wnt/    -cat signaling could 
reconstitute BBB characteristics in cultured mouse brain micro-
vascular ECs (MBEs). Because it is essentially impossible to 
culture MBEs from embryos or pups, we developed an in vitro 
assay using MBEs from young adult mice, which are known to 
rapidly loose BBB characteristics in culture ( Liebner et al., 2000b ). 
Passaged MBEs were cultured for 6 d in either control or condi-
tioned medium (CM) of L cells, producing Wnt3a, which acts 
through     -cat (  Willert et al., 2003  ), or Wnt5a, which does not 
stabilize     -cat in ECs (  Chen et al., 2003  ). 
  Treatment of MBEs with Wnt3aCM resulted in markedly 
stronger junctional staining of Cldn3 compared with controlCM 
(  Fig. 3 A  , a and e). The localization and staining intensity of 
Cldn5, ZO-1, Plako, and VE-cad was unaffected (  Fig. 3 A  , b 
and f; and not depicted). Freeze-fracture analysis revealed more 
TJ strands in Wnt3aCM-treated cells, regularly showing areas 
of high protoplasmic fracture face (P-face) association of TJ 
particles, resembling TJs of BBB ECs in vivo (  Fig. 3 A  , d and h). 
As a control, we activated MBEs with Wnt5aCM, which closely 
corresponds to control conditions concerning Cldn3, Cldn5, 
and active     -cat staining as well as TJ particle distribution on 
the P-face (  Fig. 3 A  , i  –  l). Quantitative RT-PCR and Western 
blotting confi  rmed the up-regulation of Cldn3 in Wnt3aCM 
but not in Wnt5aCM-stimulated cells on the mRNA and pro-
tein level, respectively (  Fig. 3, B and C  ). As expected, nuclear 
immunolabeling and Western blotting of activated    -cat  and 
induction of the canonical Wnt target gene Axin2 (  Fig. 3, A  , JCB • VOLUME 183 • NUMBER 3 • 2008  414
controlled by Wnt/    -cat. Recently, the transporters p-glycoprotein 
and MDR-1 were shown to be up-regulated by specifi  c GSK3    
inhibitors in rat brain ECs (  Lim et al., 2008  ). Our own prelimi-
nary results did not confi  rm a regulation of p-glycoprotein and 
MDR-1 but indicate that Abcg2 and the glucose transporter 
Slc2a1 were notably up-regulated in MBEs by Wnt3aCM 
(unpublished data). Although further studies need to elucidate 
the entire set of BBB-related genes directly or indirectly regu-
lated by Wnt/    -cat, these fi  ndings fi  t well with the concomitant 
down-regulation of Plvap by active     -cat in vitro and in vivo. 
Plvap is associated with vessels with high vesicular transport 
and negatively correlates with the development of the BBB 
(  Hallmann et al., 1995  ). Conversely, BBB microvessels up-
regulate Plvap under pathological conditions such as Alzheimer  ’  s 
disease, brain tumors, and stroke (  Sparks et al., 2000  ;   Carson-
Walter et al., 2005  ). 
  In conclusion, we provide fi  rst and direct evidence for the 
role of the canonical Wnt pathway as a key regulator of the BBB 
phenotype in ECs. The BBB is indispensable for brain function, 
and understanding the molecular mechanisms, which determine 
for defective BBB (  Nitta et al., 2003  ), data reported in this study 
and in previous work (  Wolburg et al., 2003  ) strongly suggest that 
Cldn3 is a major determinant of BBB, cooperating with Cldn5 
in maintaining low permeability. The precise mechanism through 
which     -cat regulates the expression of Cldn3 is yet to be de-
fi  ned, but the promoter contains consensus-binding domains for 
the TCF – Lef –    -cat transcriptional complex (unpublished data). 
Recently, we demonstrated that     -cat can stabilize FoxO-1 bind-
ing to the Cldn5 promoter, contributing to its repression (  Taddei 
et al., 2008  ). In this study, we found that     -cat in vivo is required 
to maintain high levels of Cldn5 expression in brain micro-
vasculature. Although we do not know the exact mechanism 
of this regulation in brain microvasculature, it is likely that the 
transcriptional role of     -cat varies depending on the special-
ized region of the vascular tree. Other BBB-related Cldns, 
such as Cldn1 and Cldn12, were not signifi  cantly modifi  ed by 
   -cat  signaling. 
  In this study, we mostly focus on the role of canonical 
Wnt signaling on vascular junction organization and permeabil-
ity control. However, other barrier-associated genes may also be 
  Figure 4.           -Cat LOF and GOF in MBEs in vitro.       -Cat 
lox/lox   and     -cat 
lox(ex3)/lox(ex3)   MBEs were treated with TAT-Cre in vitro to achieve     -cat LOF and GOF, 
respectively. (A, a  –  c and f  –  h)     -Cat 
lox/lox   with or without TAT-Cre, stimulated with controlCM (CCM) or Wnt3aCM. IF staining reveals increased junctional 
Cldn3 in Cre 
     /Wnt3aCM and a complete absence of     -cat in Cre 
+  /Wnt3aCM. (d, e, i, and j)     -Cat 
lox(ex3)/lox(ex3)   MBEs with or without TAT-Cre, and IF 
stained for Cldn3 and     -cat. Arrowheads point to nuclear     -cat. (B) Quantitative RT-PCR for Cldn3 in Cre 
     /Wnt3aCM-treated cells from     -cat 
lox/lox   (  n   = 3; 
**, P = 0.0048) and in Cre 
+  /controlCM cells from     -cat 
lox(ex3)/lox(ex3)   (  n   = 3; *, P = 0.0341) mice. Other tested genes were not signiﬁ  cantly altered. Axin2 
induction conﬁ  rmed canonical Wnt signaling in Cre 
     /Wnt3aCM-treated cells from     -cat 
lox/lox   (  n   = 3; **, P = 0.0006) and in Cre 
+  /controlCM cells from 
    -cat 
lox(ex3)/lox(ex3)   (  n   = 3; **, P = 0.0029) mice. Controls are set as 100% (dashed lines). Error bars represent SEM. (C) Western blot analysis for Cldn3 
in     -cat 
lox/lox   and     -cat 
lox(ex3)/lox(ex3)   cells. Transcription and translation of an N-terminal truncated form of     -cat are detected by the anti  –      -cat antibody and 
represented by the bottom band in     -cat 
lox(ex3)/lox(ex3)  /Cre 
+   cells. See graphs for densiomeric quantiﬁ  cation of Western blot bands. Data are representative 
of at least three independent experiments.     415 WNT/    -CATENIN SIGNALING IN BBB ENDOTHELIA   • Liebner et al. 
5   μ  g/ml EC growth supplement [homemade from calf brain], 100 U/L 
penicillin/streptomycin, 2 mM glutamin, 1  ×   MEM, and 1 mM Na-pyruvate) at 
a density of 1.5   ×   10 
4   cells/ml on collagen I  –  coated wells. ECs were se-
lected for puromycin (4   μ  g/ml) resistance for 2 d, grown to conﬂ  uency and 
passaged 1:2, and grown for an additional 6 d in the presence of control, 
Wnt3a, or Wnt5aCM. Cells were ﬁ  xed with methanol for immunoﬂ  uores-
cent staining or lysed for RNA and protein, respectively. 
  Viral preparations 
  The lentiviral construct Lef    N-    CTA lacking the armadillo repeats with con-
stitutive TCF  –      -cat transcriptional activity was used. The day after splitting, 
MBEs were infected with lenti-GFP or lenti  –  Lef  Δ  N-    CTA (provided by 
K. Vleminckx, University of Gent, Gent, Belgium;   Vleminckx et al., 1999  ) 
and ﬁ  xed or extracted after 1 wk. Lentiviral and packaging plasmids were 
provided by L. Naldini (San Raffaele Telethon Institute for Gene Therapy, 
Milan, Italy) and produced as described previously (  Dull et al., 1998  ). 
Adenoviral dnTCF4 was provided by S.J. George (Bristol Heart Institute, 
Bristol, England, UK;   Quasnichka et al., 2006  ). The day after splitting, one 
barrier properties in ECs, will greatly contribute to the develop-
ment of new therapeutic strategies to modulate the BBB in the 
treatment for stroke, multiple sclerosis, and brain tumors. 
  Materials and methods 
  Animals 
  The following transgenic mouse strains were used:     -cat 
lox(ex3)/lox(ex3)   
(  Harada et al., 1999  ),     -cat 
lox/lox   (  Brault et al., 2001  ), Pdgfb-iCreER (  Claxton 
et al., 2008  ), and BAT-Gal/C57Bl6 (  Maretto et al., 2003  ). For MBE prep-
aration, C57Bl6 wild-type mice were used (Charles River Laboratories). 
  Preparation of primary mouse brain ECs 
  Mouse brain microvascular fragments were processed as described previ-
ously (  Liebner et al., 2000b  ;   Calabria et al., 2006  ). Capillary fragments 
were seeded in culture medium (DME, 20% FCS, 100   μ  g/ml heparin, 
  Figure 5.       Cldn3 up-regulation requires transcriptionally active rather than junctional     -cat in MBEs in vitro.   (A, a  –  c; and B, a) MBEs were either treated 
with Wnt3aCM or control CM and infected with dnTCF4 adenovirus or a control. (A, a  –  c) IF stainings for Cldn3. dnTCF4 abrogated the effect of Wnt3aCM 
on junctional Cldn3. (B, a) Quantitative RT-PCR for Cldn3 (  n   = 3; **, P = 0.0095), Plvap (  n   = 3; *, P = 0.035), and Axin2 (  n   = 3; **, P = 0.004) with 
Wnt3aCM and for Plvap (  n   = 3; **, P = 0.002) with Wnt3aCM and dnTCF4. (A, d; and B, b) MBEs infected with Lef  Δ  N-    CTA lentivirus or a control. 
Junctional localization of Cldn3 increased in IF stainings. Quantitative RT-PCR for Cldn3 (  n   = 3; **, P = 0.002), Plvap (  n   = 3; **, P = 0.008), and Axin2 
(  n   = 3; **, P   <   0.0001). Controls are set as 100% (dashed lines). Green nuclei show an anti  –  V5-TAG (c) and an anti  –  HA-TAG (d) staining of dnTCF4 and 
Lef  Δ  N-    CTA, respectively, conﬁ  rming infection of the target cells. Error bars represent SEM.     JCB • VOLUME 183 • NUMBER 3 • 2008  416
Plan-Neoﬂ  uar 25  ×   NA 0.80w, and C Apochromat 40  ×   NA 1.2w. Digital 
zoom factor two or three was used for detail panels. Images and stacks 
were processed using ImageJ (National Institutes of Health) and Photoshop 
(CS; Adobe). 
  RNA preparation and quantitative RT-PCR 
  Total RNA from cultured cells was prepared with the RNeasy Mini kit 
(QIAGEN) according to the manufacturer  ’  s protocol. RNA was reverse tran-
scribed with the Transcriptor First Strand cDNA Sythesis kit (Roche) using 
1   μ  g of total RNA per 20-  μ  l reaction. For real-time PCR reactions, Absolute 
Quantitative RT-PCR SYBR Green Fluorescein Mix (Thermo Fisher Scientiﬁ  c) 
was used as described in the protocol on a DNA Engine Opticon 2 (Bio-
Rad Laboratories). 
  The following primers were used for identiﬁ  cation: Cldn1 (sense 
5    -GATGTGGATGGCTGTCATTGG-3    , antisense 5    -ACACCTCCCAG  AAGG-
C  AGAGG-3    ), Cldn3 (sense 5    -CGTACAAGACGAGACGGCCAAG-3    , 
antisense 5    -CACGTACAACCCAGCTCCCATC-3    ), Cldn5 (sense 5    -AT-
GTCGTGCGTGGTGCAGAGT-3    , antisense 5    -GCGCCGGTCAAGGTAA-
CAAAG-3    ), Cldn12 (sense 5    -CAGACAGGCTGCTTGGAGAAAC-3    , 
antisense 5    -AGGCAATACCACACAGGAAGGA-3    ), Ocln (sense 5    -GT-
GAATGGCAAGCGATCATACC-3    ,  antisense  5    -TGCCTGAAGTCATCCACA-
CTCA-3    ), Plvap (sense 5    -GACTACGCGACGTGAGATGGA-3    , antisense 
5    -AGGATGATAGCGGCGATGAAG-3    ), and Axin2 (sense 5    -GCCGACCT-
CAAGTGCAAACTC-3    , antisense 5    -GGCTGGTGCAAAGACATAGCC-3    ) 
and, as reference for the house keeping genes, RNA polymerase II (sense 
5    -ATGAGCTGGAACGGGAATTTGA-3    , antisense 5    -ACCACTTTGATGGGAT-
GCAGGT-3    ) and glucose-6-phosphate dehydrogenase (sense 5    -GGAC-
GACATCCGAAAGCAGAGT-3    , antisense 5    -GAATAGACGGTTGGCCT-
GCATC-3    ). Quantitative RT-PCR conditions were 15 min at 95  °  C, 40 
cycles of 15 s at 94  °  C, 30 s at 60  °  C, and 30 s at 72  °  C. For intron less 
genes, negative RT controls were performed to exclude the possibility of 
  genomic background. 
  Western blotting 
  Western blot analysis was performed according to standard protocols. 
In brief, conﬂ  uent cells were washed with ice-cold PBS and scraped in lysis 
buffer (50 mM Tris and 150 mM NaCl, pH 7.4, containing 1% Triton 
X-100, 1% Nonidet P-40, 0.5% sodium-deoxycholate, 0.1% sodium-
dodecyl-sulfate, 1 mM phenylmethylsulfonyl ﬂ  uoride, 15   μ  g/ml leupeptin, 
71   μ  g/ml phenanthrolyne, and 20 U/ml aprotine [Sigma-Aldrich]). The in-
soluble material was removed by centrifugation at 12,000 rpm for 10 min. 
Alternatively, cultured cells were lysated by boiling in a modiﬁ  ed laemli 
sample buffer (2% SDS, 20% glycerol, and 125 mM Tris-HCl, pH 6.8). The 
protein content was measured according to the bicinchoninic acid method 
(Thermo Fisher Scientiﬁ  c). Total cell lysates were separated by SDS-PAGE 
under reducing conditions, transfered to a nitrocellulose membrane, and 
analyzed by immunoblotting with speciﬁ  c antibodies. 
  Freeze fracturing 
  Freeze fracturing on glutaraldehyde-ﬁ   xed ECs was performed as previ-
ously described (  Liebner et al., 2000b  ). Negatives were digitized, and im-
ages were arranged in Photoshop. 
  Statistical analysis 
  Results are presented as mean   ±   SEM. A two-tailed Student  ’  s   t   test was 
used to analyze the difference between two groups. Values were regarded 
as signiﬁ  cant at P   <   0.05. 
  Online supplemental material 
  Fig. S1 shows that conditional inactivation of     -cat in ECs of postnatal mice 
led to down-regulation of Cldn3 and Cldn5 and increased permeability in 
brain capillaries. Fig. S2 shows that conditional activation of     -cat transcrip-
tional activity induced Cldn3 only in brain vessels of early postnatal mice. 
Fig. S3 shows that activated     -cat can induce Cldn3 and TJ formation in a 
nonbrain-derived endothelioma cell line. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200806024/DC1. 
  The MECA-32/Plvap antibody was provided by R. Hallmann. We thank 
S. Thom, A. Siepmann, and R. Knittel for excellent technical support. Many 
thanks to G. Elia (London Research Institute, London, England, UK) for frozen 
sections and advice on IHC and to L. Davinson for proofreading. We are 
grateful to S. Watling, C. Thrussell, and C. Darnborough for excellent animal 
husbandry and assistance with tamoxifen and Evans blue injections as well as 
tissue harvesting. 
  This study was supported by the Deutsche Forschungs Gemeinschaft 
(research group 501 vascular homeostasis, PL 158/7-3 to S. Liebner and 
set of cells was treated with Wnt3aCM, and when they reached conﬂ  uency, 
they were infected with Ad-GFP or Ad-dnTCF4. 72 h later, the infection 
cells were ﬁ  xed or extracted for quantitative RT-PCR. 
  Conditional deletion/activation of     -cat in vivo and in vitro 
  ECs were treated with 50   μ  g/ml TAT-Cre for 60 min in DME without 
serum followed by 100   μ  M chloroquine for 30 min (  Wadia et al., 2004  ). 
The cells were washed with DME and cultured with complete medium with 
or without WntCM. 
  For     -cat deletion, in vivo Pdgfb-iCreERT2 (  Claxton et al., 2008  ) lines 
were crossed to mice harboring ﬂ   oxed alleles of     -cat (    -cat 
lox/lox  ;   Brault 
et al., 2001  ) to obtain homozygous ﬂ  oxed     -cat 
lox/lox   pups, of which 50% 
also carried one Pdgfb-iCreERT2 allele. 4OHT (Sigma-Aldrich) was dissolved 
in absolute ethanol at 20 mg/ml, diluted to 4 mg/ml in sterile peanut oil, 
and injected i.p. at 20   μ  l/g into pups 3 d before tissue harvesting. When 
harvesting embryonic tissues at E13.5, the mothers were injected with 1 mg 
4OHT at E11.5 and 12.5. For control experiments on promoter activity and 
recombination frequency, see Online supplemental material. 
  Evans blue permeability 
  A 1% sterile solution of Evans blue (Sigma-Aldrich) in PBSa was injected 
i.p. 18  –  24 h before the animals were harvested. To remove the Evans blue 
from the vasculature, the mice were perfused with PBSa while under termi-
nal anesthesia. Frozen 12-  μ  m sections of brain and 15-  μ  m sections of skin 
were dried onto slides for approximately 10 min at 37  °  C (provided by 
G. Elia, Cancer Research Institute, London, England, UK). They were ﬁ  xed in 
4  °  C acetone for 2 min, air dried, dipped in xylene, and mounted in dibutyl 
polystyrene xylene (  Hamer et al., 2002  ). 
  Antibodies 
  The following mouse mAbs were used: anti  –      -tubulin and anti-Cldn5 (Invitro-
gen), anti  –      -cat (BD Biosciences), and antiactive     -cat (8E7; Millipore). Rat 
anti-PECAM/CD31 clone MEC13.3 mAb has been described previously 
(  Vecchi et al., 1994  ). Rat anti  –  VE-cad clone BV13 mAb has been described 
previously (  Lampugnani et al., 2002  ). Rat monoclonal anti  –  MECA-32/Plvap 
mAb was provided by R. Hallmann (University of M  ü  nster, M  ü  nster, Germany; 
  Hallmann et al., 1995  ). 
  The following polyclonal antibodies were used: goat anti  –      -galacto-
sidase (Abcam), rabbit anti-Cldn3 and rabbit anti  –  ZO-1 (Invitrogen), rab-
bit anti –  collagen IV (AbD Serotec), biotinylated isolectin B4 (Sigma-Aldrich), 
and Alexa Fluor direct-conjugated isolectin 568 and 488 (Invitrogen). 
  The following secondary antibodies were used: appropriated anti-
bodies and streptavidin conjugates Alexa Fluor 350, 488, 555, 568, and 
633 were purchased from Invitrogen (the anti  –  mouse antibodies were 
highly cross-absorbed against nonspeciﬁ   c mouse proteins). For nuclear 
stain on brain sections, Hoechst 333258 was diluted to 1   μ  g/ml in PBS/0.2% 
Tween 20 and incubated at RT for 5 min. Alternatively, TOTO-3 (1:1,000; 
Invitrogen) was used. 
  Immunohistochemistry (IHC) 
      -Galactosidase staining of BAT-Gal embryos was performed as previously 
described (  Liebner et al., 2004  ). Hindbrains were dissected out from PFA-
ﬁ  xed embryos, washed in PBS, and subjected to isolectin. LacZ was either 
detected as reﬂ  ection of the 488-nm laser or by antibody staining as indi-
cated. Eyes were ﬁ  xed in PFA for 5 min on ice, and retinas were subse-
quently dissected in cold PBSa. Retinas were ﬁ  xed in 4  °  C methanol and 
stored at     20  °  C. Before staining, the retinas were placed in PBSa to rehy-
drate. Retinas were incubated in blocking buffer (1% BSA + 0.5% Triton 
X-100 in PBSa) for 1 h. Immunoﬂ  uorescent staining with anti  –  collagen IV, 
Cldn5, MECA-32/Plvap, VE-cad, ZO-1, and     -cat was performed as previ-
ously described (  Gerhardt et al., 2003  ). Appropriate Alexa Fluor  –  conju-
gated secondary antibodies were used for detection. 
  Brains were isolated, placed in Tissue Tek (Sakura Finetek), and 
slowly frozen in liquid nitrogen vapor. 10  –  12-  μ  m cryosections were ﬁ  xed 
and stained as described previously (  Liebner et al., 2000a  ). 
  Flat mounted hindbrains were analyzed by ﬂ  uorescence microscopy 
using a microscope (80i; Nikon;) with a 20  ×   NA 0.75 or 40  ×   NA 1.4 
oil/RT objective equipped with a digital camera (DS-5Mc; Nikon). Mea-
surements were performed by using NIS Elements software (version 3.0; 
Nikon). Alternatively, images were captured by confocal laser-scanning 
microscopy using a C1si microscope (Nikon) with a 40  ×   NA 1.4 oil/RT 
objective or an LCS NT microscope (Leica). Retinas and brain sections 
were analyzed at RT by confocal laser-scanning microscopy using an up-
right microscope (LSM 510; Carl Zeiss, Inc.) with 405-, 488-, 543-, and 
633-nm laser lines. The lenses used were C Apochromat 10  ×   NA 0.45w, 417 WNT/    -CATENIN SIGNALING IN BBB ENDOTHELIA   • Liebner et al. 
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